Nifedipine: Difference between revisions
No edit summary |
No edit summary |
||
| Line 24: | Line 24: | ||
'''| [[Nifedipine description|Description]]''' | '''| [[Nifedipine description|Description]]''' | ||
'''| [[Nifedipine clinical pharmacology|Clinical Pharmacology]]''' | '''| [[Nifedipine clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[Nifedipine how supplied storage and handling|How Supplied/Storage and Handling]]''' | '''| [[Nifedipine how supplied storage and handling|How Supplied/Storage and Handling]]''' | ||
'''| [[Nifedipine patient counseling information|Patient Counseling Information]]''' | '''| [[Nifedipine patient counseling information|Patient Counseling Information]]''' | ||
Revision as of 23:08, 26 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: : Abdurahman Khalil, M.D. [2]
For patient information about Nifedipine, click here.
Synonyms / Brand Names:Adalat®, Adalat 10®, Adalat 20®, Adalat 5®, Adalat CC®, Adalat CR®, Adalat Crono®, Adalat Ft®, Adalat Gits®, Adalat Gits 30®, Adalat LA®, Adalat LP®, Adalat Oros®,Adalat PA®, Adalat Retard®, Adalate®, Adapine®, Adapress®, Alat®, Aldipin®, Alfadal®, Alonix®, Alonix S®, Alpha-Nifedipine Retard®, Angipec®, Anifed®, Anpine®, Apo-Nifed®, Aprical®, Bonacid®, Calcibloc®, Calcigard®, Calcilat®, Camont®, Cardifen®, Cardilat®, Cardionorm®, Chronadalate®, Chronadalate Lp®, Citilat®, Coracten®, Coral®, Cordafen®, Cordaflex®, Cordalat®, Cordicant®, Cordilan®, Cordipin®, Corinfar®, Corotrend®, Corynphar®, Depin®, Dignokonstant®, Dilafed®, Dilcor®, Dipinkor®, Duranifin®, Ecodipi®, Ecodipin®, Ecodipin E®, Fedcor®, Fedcor Retard®, Fenamon®, Fenamon Sr®, Fenihidin®, Fenihidine®, Glopir®, Hadipin®, Hexadilat®, Introcar®, Kordafen®, Macorel, Megalat®, Myogard®, N1fedilat®, Nedipin®, Nicardia®, Nifangin®, Nifar®, Nifdemin®, Nifebene®, Nifecard®, Nifecor®, Nifedepat®, Nifedicor®, Nifedin®, Nifedine®, Nifedipine Retard®, Nifedipres®, Nifedirex LP®, Nifelan®, Nifelat®, Nifelat Q®, Nifelate®, Nifensar XL®, Nificard®, Nifidine®, Nifipen®, Niphedipine®, Orix®, Oxcord®, Pidilat®, Procardia®, Procardia XL®, Sepamit®, Tibricol®, Zenusin®
Overview
Nifedipine is a dihydropyridine calcium channel blocker that primarily blocks L-type calcium channels.[1] Its main uses are as an antianginal (especially in Prinzmetal's angina) and antihypertensive, although a large number of other indications have recently been found for this agent, such as Raynaud's phenomenon, premature labor, and painful spasms of the esophagus such as in cancer and tetanus patients. It is also commonly used for the small subset of pulmonary hypertension patients whose symptoms respond to calcium channel blockers.
Category
FDA Package Insert
NIFEDIPINE®
Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages
Mechanism of Action
References
- ↑ Hayashi K, Homma K, Wakino S, Tokuyama H, Sugano N, Saruta T, Itoh H (2010). "T-type Ca channel blockade as a determinant of kidney protection". Keio J Med. 59 (3): 84–95. doi:10.2302/kjm.59.84. PMID 20881449.
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=03be089c-07e5-4f94-bfcc-c6101b311785